A series of isoindolo-benzo-triazines of type 4 was obtained by diazotization of 2-(2-aminoaryl)-1-cyanoisoindoles 3a-j. All the synthesized derivatives were screened by the National Cancer Institute (NCI, Bethesda, USA), for in vitro antitumor activity against a 3-human cancer cell line panel consisting of MCF7 (breast), NCI-H460 (lung), and SF-268 (CNS). Derivatives 4a, f, i, j were selected to be
通过2-(2-
氨基芳基)-1-
氰基异
吲哚3a-j的重氮化获得一系列类型4的异
吲哚-苯并三嗪。美国国家癌症研究所(NCI,Bethesda,U
SA)对所有合成的衍
生物进行了筛选,以针对由MCF7(乳腺癌),NCI-H460(肺)和SF- 268(CNS)。选择衍
生物4a,f,i,j,以对来自九种人类癌细胞类型的约50种人类肿瘤
细胞系进行全面评估,并通常在微摩尔范围内显示出抗增殖活性。最敏感的
细胞系是:白血病亚组的MOLT-4和SR,非小细胞肺亚组的A549 / A
TCC和EKVX,结肠癌亚组的COLO-205,黑素瘤亚组的LOX IMVI,O
VCAR-8。卵巢癌子面板和MCF7,